Vascular News
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
9th October 2023
Forty five-year legacy of CX vascular education continues
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and death that...
Rates of stroke, death and myocardial infarction post-TCAR do not differ by patient...
Multicentre study points to favourable safety and efficacy of radial access for peripheral...
Latest News
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system...
26th October 2023Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...
Thrombolex announces new insights from the RESCUE trial with the Bashir...
26th October 2023
TCT 2023: LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough...
25th October 2023
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...
24th October 2023
Robocath completes CARE clinical trial evaluating robotic carotid stenting
19th October 2023Features
Vascular News’ top 10 most popular stories of September 2023
11th October 2023Discussions on the role of aritifical intelligence in the vascular field and emerging deep venous valve technologies caught readers' attention in September. 1. Humacyte announces...
Forty five-year legacy of CX vascular education continues
10th October 2023Three newly appointed Charing Cross International Symposium (CX) co-chairs will ensure Roger Greenhalgh’s inspiring legacy of vascular education continues at CX 2024 with the...
Videos
Five-year RCT data provide upbeat message on Luminor paclitaxel-coated balloon’s safety and efficacy
16th October 2023NOTE: This video is ONLY available to watch in selected countries and geographies The EffPac trial was a prospective, multicentre, randomised controlled trial (RCT) that enrolled 171 patients of Rutherford category two to four with medium-length femoropopliteal lesions. Patients...
Events
MON 30 OCT 2023 THU 02 NOV 2023Vascular Interventional Advances (VIVA) 2023
Las Vegas, USAW: viva-foundation.org/future-meetings
WED 08 NOV 2023 FRI 10 NOV 2023Paris Vascular Insights (PVI)
Paris, FranceW: www.paris-vascular-insights.com
TUE 14 NOV 2023 SAT 18 NOV 2023VEITHsymposium 2023
New York, USAW: www.veithsymposium.org/index.php
Most read in past 7 days
CX 2020 LIVE: Strong support for relining peripheral arteries and rivaroxaban use for widespread atherosclerosis
11th June 2020TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...
24th October 2023
Sex found to be “important variable” in study and treatment of...
1st February 2023Features
Vascular News’ top 10 most popular stories of September 2023
11th October 2023
Forty five-year legacy of CX vascular education continues
10th October 2023
Deep venous valve technologies set to address “large unmet need worldwide”
13th September 2023Profiles
Rachel Bell
28th July 2023
Jon Boyle
20th February 2023
Markus Steinbauer
21st December 2022
Write to us
Editor: Jocelyn Hudson [email protected]
Advertising: Rav Pankhania [email protected]
United Kingdom
BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]
United States
BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]
Terms and Conditions | Privacy Policy
